Independent
Tenure on this board
2.4 yrs
Also a director at
Gentherm Inc (THRM)Orthofix Medical Inc (OFIX)
Meeting calendar
QSI · Annual meeting · Friday, May 15, 2026
Quantum-si Inc
10 nominees · 3 ballot items.
Elect ten directors; ratify PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026; approve, on a non-binding advisory basis, named executive officer compensation.
Market cap
$267M
1Y TSR
-55.3%
Board grade
C-
Record date
Mar 20, 2026
Filing
DEF 14A
Meeting concluded · May 15, 2026
Follow how the vote landed and what changed on Quantum-si Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect ten directors to serve one-year terms expiring in 2027.
- 2
Ratification of Selection of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
- 3
Non-Binding, Advisory Vote on Approval of Executive Compensation
ManagementBoard: FORApprove, on a non-binding, advisory basis, the compensation of the named executive officers as disclosed in this proxy statement.
More detail
This management proposal asks shareholders to cast a non-binding advisory vote to approve the compensation of the company's named executive officers as disclosed in the proxy statement. Management seeks this advisory approval to demonstrate shareholder support for its executive pay program and compensation philosophy, which ties pay to both short- and long-term performance metrics and uses equity-based awards and performance conditions to align management incentives with shareholder interests. The board recommends a vote FOR this resolution; it emphasizes that while the vote is non-binding, the compensation committee and the board will review the outcome and consider it when making future compensation decisions. Context includes the company's controlled-company status (where one holder controls majority voting power), the use of performance-based equity awards with market-based vesting conditions and recent amendments to those awards, and the company's disclosed pay-versus-performance metrics. The proposal is typical say-on-pay practice required by SEC rules and is intended to provide feedback to the board but does not alter compensation directly even if opposed. The management recommendation cites alignment with strategy and retention of key executives as rationale for support.
Director elections
Nominees on the ballot10
Not independent
Tenure on this board
4.0 yrs
Independent
Tenure on this board
2.5 yrs
Independent
Tenure on this board
6.1 yrs
Also a director at
Hyperfine Inc (HYPR)
Independent
Tenure on this board
3.0 yrs
Independent
Tenure on this board
3.4 yrs
Also a director at
Orasure Technologies Inc (OSUR)Neogenomics Inc (NEO)
Independent
Tenure on this board
5.3 yrs
Also a director at
Elutia Inc (ELUT)
Independent
Tenure on this board
3.4 yrs
Also a director at
Quanterix Corp (QTRX)
Independent
Tenure on this board
6.3 yrs
Also a director at
Elutia Inc (ELUT)
Not independent
Tenure on this board
5.3 yrs
Also a director at
Butterfly Network Inc (BFLY)Hyperfine Inc (HYPR)
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 3.5% | 7,578,208 | $7M |
| 2 | ARK Investment Management LLC | 3.3% | 7,167,738 | $6M |
| 3 | Amova Asset Management Americas, Inc. | 1.8% | 3,885,230 | $3M |
| 4 | Sumitomo Mitsui Trust Group, Inc. | 1.8% | 3,885,230 | $3M |
| 5 | BlackRock, Inc. | 1.5% | 3,221,675 | $3M |
| 6 | MILLENNIUM MANAGEMENT LLC | 1.4% | 3,131,726 | $3M |
| 7 | UBS Group AG | 1.2% | 2,522,667 | $2M |
| 8 | AQR CAPITAL MANAGEMENT LLC | 1.0% | 2,281,337 | $2M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 0.8% | 1,841,065 | $2M |
| 10 | BlackRock, Inc. | 0.8% | 1,641,869 | $1M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Quantum-si Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Tilray Brands IncTLRY
Annual meeting·Nov 18, 2026·$506M
Weave Communications IncWEAV
Special meeting·Oct 22, 2026·$590M
Varex Imaging CorpVREX
Special meeting·Oct 28, 2026·$776M
Phibro Animal Health CorpPAHC
Annual meeting·Nov 3, 2026·$1.5B
Supernus Pharmaceuticals IncSUPN
Special meeting·Oct 15, 2026·$2.5B
Integer Holdings CorpITGR
Special meeting·Oct 21, 2026·$4.3B
Reference
Frequently asked questions
- When is the Quantum-si Inc 2026 annual meeting?
- Quantum-si Inc (QSI) holds its 2026 annual shareholder meeting on Friday, May 15, 2026.
- What is the record date for the Quantum-si Inc 2026 meeting?
- The record date for the Quantum-si Inc 2026 meeting is Friday, March 20, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Quantum-si Inc's 2026 meeting?
- The board is presenting 10 director nominees at the Quantum-si Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Quantum-si Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Quantum-si Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.